Moomoo AI 已提取核心信息
In a recent transaction, Robin Toft, a reporting person for T2 Biosystems, Inc. [TTOO], engaged in a stock market action on January 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Additionally, the relationship of Robin Toft to the issuer, T2 Biosystems, was not specified. The transaction's status, whether it was a purchase, sale, or another type of action, was also not provided in the available information.
In a recent transaction, Robin Toft, a reporting person for T2 Biosystems, Inc. [TTOO], engaged in a stock market action on January 1, 2024. The specific details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. Additionally, the relationship of Robin Toft to the issuer, T2 Biosystems, was not specified. The transaction's status, whether it was a purchase, sale, or another type of action, was also not provided in the available information.
在最近的一笔交易中，T2 Biosystems, Inc. [TTOO] 的举报人罗宾·托夫特于2024年1月1日参与了股市交易。该交易的具体细节，包括所涉及的股票数量、股票的性质、交易价格和股票的总价值，未在公告中披露。此外，没有具体说明罗宾·托夫特与发行人T2 Biosystems的关系。现有信息中也没有提供该交易的状态，无论是购买、出售还是其他类型的行动。
在最近的一笔交易中，T2 Biosystems, Inc. [TTOO] 的举报人罗宾·托夫特于2024年1月1日参与了股市交易。该交易的具体细节，包括所涉及的股票数量、股票的性质、交易价格和股票的总价值，未在公告中披露。此外，没有具体说明罗宾·托夫特与发行人T2 Biosystems的关系。现有信息中也没有提供该交易的状态，无论是购买、出售还是其他类型的行动。
有用
没用